-+ 0.00%
-+ 0.00%
-+ 0.00%

ARRIVENT ANNOUNCES INITIAL PHASE 1 DATA FOR CDH17-TARGETED ADC ARR-217 IN PATIENTS WITH GASTROINTESTINAL CANCERS AT ESMO CONGRESS 2026

Reuters·10/25/2026 13:00:01

Please log in to view news